S&P 500   3,324.41 (-0.10%)
DOW   27,218.19 (+0.06%)
QQQ   270.64 (-0.15%)
AAPL   445.32 (+1.15%)
MSFT   212.46 (-0.23%)
FB   253.10 (+1.60%)
GOOGL   1,485.08 (+0.40%)
AMZN   3,187.54 (-0.55%)
NVDA   447.68 (-0.84%)
CGC   18.42 (-4.11%)
BABA   260.11 (-1.81%)
TSLA   1,492.90 (+0.53%)
MU   48.93 (-4.15%)
GE   6.39 (-0.16%)
AMD   85.34 (+0.04%)
T   30.01 (+0.54%)
F   6.94 (-0.29%)
ACB   10.29 (-3.92%)
GILD   68.72 (-0.41%)
NFLX   502.04 (-0.01%)
DIS   128.12 (+0.40%)
BAC   25.48 (+0.35%)
BA   172.45 (-1.05%)
S&P 500   3,324.41 (-0.10%)
DOW   27,218.19 (+0.06%)
QQQ   270.64 (-0.15%)
AAPL   445.32 (+1.15%)
MSFT   212.46 (-0.23%)
FB   253.10 (+1.60%)
GOOGL   1,485.08 (+0.40%)
AMZN   3,187.54 (-0.55%)
NVDA   447.68 (-0.84%)
CGC   18.42 (-4.11%)
BABA   260.11 (-1.81%)
TSLA   1,492.90 (+0.53%)
MU   48.93 (-4.15%)
GE   6.39 (-0.16%)
AMD   85.34 (+0.04%)
T   30.01 (+0.54%)
F   6.94 (-0.29%)
ACB   10.29 (-3.92%)
GILD   68.72 (-0.41%)
NFLX   502.04 (-0.01%)
DIS   128.12 (+0.40%)
BAC   25.48 (+0.35%)
BA   172.45 (-1.05%)
S&P 500   3,324.41 (-0.10%)
DOW   27,218.19 (+0.06%)
QQQ   270.64 (-0.15%)
AAPL   445.32 (+1.15%)
MSFT   212.46 (-0.23%)
FB   253.10 (+1.60%)
GOOGL   1,485.08 (+0.40%)
AMZN   3,187.54 (-0.55%)
NVDA   447.68 (-0.84%)
CGC   18.42 (-4.11%)
BABA   260.11 (-1.81%)
TSLA   1,492.90 (+0.53%)
MU   48.93 (-4.15%)
GE   6.39 (-0.16%)
AMD   85.34 (+0.04%)
T   30.01 (+0.54%)
F   6.94 (-0.29%)
ACB   10.29 (-3.92%)
GILD   68.72 (-0.41%)
NFLX   502.04 (-0.01%)
DIS   128.12 (+0.40%)
BAC   25.48 (+0.35%)
BA   172.45 (-1.05%)
S&P 500   3,324.41 (-0.10%)
DOW   27,218.19 (+0.06%)
QQQ   270.64 (-0.15%)
AAPL   445.32 (+1.15%)
MSFT   212.46 (-0.23%)
FB   253.10 (+1.60%)
GOOGL   1,485.08 (+0.40%)
AMZN   3,187.54 (-0.55%)
NVDA   447.68 (-0.84%)
CGC   18.42 (-4.11%)
BABA   260.11 (-1.81%)
TSLA   1,492.90 (+0.53%)
MU   48.93 (-4.15%)
GE   6.39 (-0.16%)
AMD   85.34 (+0.04%)
T   30.01 (+0.54%)
F   6.94 (-0.29%)
ACB   10.29 (-3.92%)
GILD   68.72 (-0.41%)
NFLX   502.04 (-0.01%)
DIS   128.12 (+0.40%)
BAC   25.48 (+0.35%)
BA   172.45 (-1.05%)
Log in

NYSE:ABCAmerisourceBergen Stock Price, Forecast & News

$103.09
-0.41 (-0.40 %)
(As of 08/6/2020 11:09 AM ET)
Add
Compare
Today's Range
$102.00
Now: $103.09▼
$103.77
50-Day Range
$96.39
MA: $100.97▼
$104.70
52-Week Range
$72.06
Now: $103.09▼
$106.45
Volume5,653 shs
Average Volume943,105 shs
Market Capitalization$20.97 billion
P/E Ratio13.56
Dividend Yield1.60%
Beta0.6
AmerisourceBergen Corporation sources and distributes pharmaceutical products in the United States and internationally. Its Pharmaceutical Distribution segment distributes brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, outsourced compounded sterile preparations, and related services to various healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and other alternate site pharmacies, and other customers. It also provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; and packaging solutions to various institutional and retail healthcare providers. In addition, this segment distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; provides other services primarily to physicians who specialize in various disease states, primarily oncology, as well as to other healthcare providers, including hospitals and dialysis clinics; and offers data analytics, outcomes research, and additional services for biotechnology and pharmaceutical manufacturers. The company's Other segment provides integrated manufacturer services, such as clinical trial support, product post-approval, and commercialization support; offers specialty transportation and logistics services for the biopharmaceutical industry; and sells pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and various other products to customers in both the companion animal and production animal markets, as well as provides demand-creating sales force services to manufacturers. AmerisourceBergen Corporation was founded in 1985 and is headquartered in Chesterbrook, Pennsylvania.
Read More
AmerisourceBergen logo

Beat the Market (BTM) Rank™

Analyst Opinion: 1.3Community Rank: 2.5Dividend Strength: 2.5Insider Behavior: 1.0Valuation: 1.9 5 -4 -3 -2 -1 -

Overall Beat the Market Rank™

1.83 out of 5 stars


Industry, Sector and Symbol

Stock Exchange NYSE
Industry Drugs, proprietaries, & sundries
Sub-IndustryHealth Care Distributors
SectorMedical
Current SymbolNYSE:ABC
Previous Symbol
CUSIP03073E10
CIK1140859
Webwww.amerisourcebergen.com
Phone610-727-7000

Debt

Debt-to-Equity Ratio0.98
Current Ratio0.97
Quick Ratio0.63

Price-To-Earnings

Trailing P/E Ratio13.56
Forward P/E Ratio13.93
P/E Growth2.01

Sales & Book Value

Annual Sales$179.59 billion
Price / Sales0.12
Cash Flow$9.53 per share
Price / Cash Flow10.82
Book Value$14.48 per share
Price / Book7.12

Profitability

EPS (Most Recent Fiscal Year)$7.09
Net Income$855.36 million
Net Margins0.85%
Return on Equity48.85%
Return on Assets3.94%

Miscellaneous

Employees22,000
Outstanding Shares203,400,000
Market Cap$20.97 billion
Next Earnings Date11/5/2020 (Estimated)
OptionableOptionable
$103.09
-0.41 (-0.40 %)
(As of 08/6/2020 11:09 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive ABC News and Ratings via Email

Sign-up to receive the latest news and ratings for ABC and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











AmerisourceBergen (NYSE:ABC) Frequently Asked Questions

How has AmerisourceBergen's stock been impacted by COVID-19 (Coronavirus)?

AmerisourceBergen's stock was trading at $84.96 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, ABC stock has increased by 20.2% and is now trading at $102.14.
View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of AmerisourceBergen?

9 Wall Street analysts have issued "buy," "hold," and "sell" ratings for AmerisourceBergen in the last year. There are currently 1 sell rating, 2 hold ratings and 6 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for AmerisourceBergen.

When is AmerisourceBergen's next earnings date?

AmerisourceBergen is scheduled to release its next quarterly earnings announcement on Thursday, November 5th 2020.
View our earnings forecast for AmerisourceBergen.

How were AmerisourceBergen's earnings last quarter?

AmerisourceBergen Corp. (NYSE:ABC) released its quarterly earnings results on Wednesday, August, 5th. The company reported $1.85 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.50 by $0.35. The firm had revenue of $45.37 billion for the quarter, compared to analyst estimates of $44.71 billion. AmerisourceBergen had a return on equity of 48.85% and a net margin of 0.85%. The firm's revenue for the quarter was up .3% compared to the same quarter last year. During the same period last year, the company posted $1.76 earnings per share.
View AmerisourceBergen's earnings history.

How often does AmerisourceBergen pay dividends? What is the dividend yield for AmerisourceBergen?

AmerisourceBergen announced a quarterly dividend on Thursday, January 30th. Investors of record on Friday, February 14th will be paid a dividend of $0.42 per share on Monday, March 2nd. This represents a $1.68 annualized dividend and a yield of 1.64%. The ex-dividend date is Thursday, February 13th. This is an increase from AmerisourceBergen's previous quarterly dividend of $0.40.
View AmerisourceBergen's dividend history.

What guidance has AmerisourceBergen issued on next quarter's earnings?

AmerisourceBergen issued an update on its FY20 earnings guidance on Wednesday, August, 5th. The company provided earnings per share guidance of $7.80-7.95 for the period, compared to the Thomson Reuters consensus EPS estimate of $7.45.

What price target have analysts set for ABC?

9 brokerages have issued twelve-month target prices for AmerisourceBergen's shares. Their forecasts range from $88.00 to $121.00. On average, they anticipate AmerisourceBergen's share price to reach $104.33 in the next twelve months. This suggests a possible upside of 2.1% from the stock's current price.
View analysts' price targets for AmerisourceBergen.

Has AmerisourceBergen been receiving favorable news coverage?

Media stories about ABC stock have been trending negative on Thursday, according to InfoTrie Sentiment. InfoTrie ranks the sentiment of news coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. AmerisourceBergen earned a media sentiment score of -2.0 on InfoTrie's scale. They also assigned news articles about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an impact on the company's share price in the next several days.
View the latest news about AmerisourceBergen.

Are investors shorting AmerisourceBergen?

AmerisourceBergen saw a decline in short interest in the month of July. As of July 31st, there was short interest totaling 3,590,000 shares, a decline of 6.5% from the July 15th total of 3,840,000 shares. Based on an average daily volume of 1,280,000 shares, the days-to-cover ratio is presently 2.8 days. Currently, 2.5% of the company's shares are short sold.
View AmerisourceBergen's Current Options Chain.

Who are some of AmerisourceBergen's key competitors?

Some companies that are related to AmerisourceBergen include McKesson (MCK), Cardinal Health (CAH), Henry Schein (HSIC), Patterson Companies (PDCO) and Owens & Minor (OMI).
View all competitors.

What other stocks do shareholders of AmerisourceBergen own?

Based on aggregate information from My MarketBeat watchlists, some companies that other AmerisourceBergen investors own include Intel (INTC), Walt Disney (DIS), AbbVie (ABBV), CVS Health (CVS), Cisco Systems (CSCO), NVIDIA (NVDA), Netflix (NFLX), Pfizer (PFE), JPMorgan Chase & Co. (JPM) and Gilead Sciences (GILD).

Who are AmerisourceBergen's key executives?

AmerisourceBergen's management team includes the following people:
  • Mr. Steven H. Collis, Chairman, Pres & CEO (Age 58)
  • Mr. James F. Cleary Jr., CFO & Exec. VP (Age 56)
  • Mr. John G. Chou, Exec. VP and Chief Legal & Bus. Officer (Age 63)
  • Dr. Robert P. Mauch PharmD, Ph.D., Exec. VP & Group Pres (Age 52)
  • Mr. Dale B. Danilewitz, Exec. VP & Chief Information Officer (Age 57)

What is AmerisourceBergen's stock symbol?

AmerisourceBergen trades on the New York Stock Exchange (NYSE) under the ticker symbol "ABC."

Who are AmerisourceBergen's major shareholders?

AmerisourceBergen's stock is owned by many different institutional and retail investors. Top institutional shareholders include Coho Partners Ltd. (0.79%), Morningstar Investment Services LLC (0.45%), ANTIPODES PARTNERS Ltd (0.34%), Sumitomo Mitsui Trust Holdings Inc. (0.31%), Swiss National Bank (0.30%) and Fort Washington Investment Advisors Inc. OH (0.28%). Company insiders that own AmerisourceBergen stock include Dale Danilewitz, Dermot Mark Durcan, Gina Clark, Henry Wadsworth Mcgee III, James F Cleary Jr, Jane E Md Henney, John G Chou, Kathleen W Hyle, Kathy H Gaddes, Lazarus Krikorian, Richard W Gochnauer, Robert P Mauch and Steven H Collis.
View institutional ownership trends for AmerisourceBergen.

Which institutional investors are selling AmerisourceBergen stock?

ABC stock was sold by a variety of institutional investors in the last quarter, including First Trust Advisors LP, Morningstar Investment Services LLC, Candriam Luxembourg S.C.A., CWM LLC, Wedge Capital Management L L P NC, Hallmark Capital Management Inc., SG Americas Securities LLC, and Sompo Asset Management Co. Ltd.. Company insiders that have sold AmerisourceBergen company stock in the last year include Gina Clark, Jane E Md Henney, John G Chou, Kathleen W Hyle, Kathy H Gaddes, Lazarus Krikorian, Robert P Mauch, and Steven H Collis.
View insider buying and selling activity for AmerisourceBergen.

Which institutional investors are buying AmerisourceBergen stock?

ABC stock was purchased by a variety of institutional investors in the last quarter, including ANTIPODES PARTNERS Ltd, Cornerstone Investment Partners LLC, Hexavest Inc., Robeco Institutional Asset Management B.V., Royal London Asset Management Ltd., Adams Diversified Equity Fund Inc., UBS Group AG, and PGGM Investments. Company insiders that have bought AmerisourceBergen stock in the last two years include Dermot Mark Durcan, and James F Cleary Jr.
View insider buying and selling activity for AmerisourceBergen.

How do I buy shares of AmerisourceBergen?

Shares of ABC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is AmerisourceBergen's stock price today?

One share of ABC stock can currently be purchased for approximately $102.14.

How big of a company is AmerisourceBergen?

AmerisourceBergen has a market capitalization of $20.78 billion and generates $179.59 billion in revenue each year. The company earns $855.36 million in net income (profit) each year or $7.09 on an earnings per share basis. AmerisourceBergen employs 22,000 workers across the globe.

What is AmerisourceBergen's official website?

The official website for AmerisourceBergen is www.amerisourcebergen.com.

How can I contact AmerisourceBergen?

AmerisourceBergen's mailing address is 1300 MORRIS DRIVE, CHESTERBROOK PA, 19087. The company can be reached via phone at 610-727-7000 or via email at [email protected]

This page was last updated on 8/6/2020 by MarketBeat.com Staff
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.